6 December 2017

GenDx has signed a global reseller agreement with Thermo Fisher Scientific assigning GenDx as a nonexclusive reseller of Applied Biosystems™ QuantStudio™ real-time PCR systems, including the QuantStudio 5, QuantStudio 6 Flex, and QuantStudio 7 Flex. Under the agreement, local distributors of GenDx are authorized to supply the above-mentioned QuantStudio systems and service contracts in their respective countries.

QuantStudio systems are compatible with GenDx KMRtype®/KMRtrack® reagents and KMRengine® software, providing a complete solution for monitoring the chimeric status of bone marrow and stem cell recipients.

Dr. Wietse Mulder, CEO of GenDx, commented: “We are very pleased to expand our partnership with Thermo Fisher Scientific to include the suite of QuantStudio real-time PCR instruments. The agreement strengthens our pioneer status in the field of chimerism monitoring and establishes GenDx as the worldwide leader of chimerism monitoring solutions using quantitative PCR. This agreement also fits our company’s mission; being an independent organization respecting our trusted and highly valued business partners. At GenDx, our efforts are focused on molecular diagnostics solutions and we combine scientific innovation with day-to-day reliability in products for diagnostics, ultimately leading to a better outcome of transplantation”.

Readers of this message, who are interested in chimerism monitoring and wonder whether they could benefit from this new agreement, can receive more information by contacting their local GenDx distributor or contacting GenDx directly.

Complete press release.